Polish Version Dyspnea in Amyotrophic Lateral Sclerosis

Sponsor
Jakub Antczak
Study ID
NCT07178574
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Amyotrophic lateral sclerosis is a fatal disease with progressive degeneration of central and peripheral motor neurons. Weakness of pharyngeal and respiratory muscles lead to dyspnea, which is present in up to 80% of patients. Dyspnea in Amyotrophic Lateral Sclerosis (DALS-15) is a questionnaire designed to measure the severity of dyspnea. DALS-15 was originally created in German language. The aim of this study is to validate the Polish-language version of DALS-15.

Key Dates

First listed
Sep 17, 2025
Start date
Oct 1, 2025
Status verified
Sep 2025
Primary completion
Dec 31, 2027
Completion
Jun 30, 2028

Study Design

Enrollment
120 participants (estimated)

Arms

  • Arm: ALS patients
    Patients with diagnosis of ALS and with complaining of dyspnea

Primary Outcome Measure

Convergent Validity - Modified Borg Dyspnea Scale upright [ Time Frame: Through study completion, an average of 1 year. ]

Central Contacts

Related Studies